ad image

Epidermolysis Bullosa

1 / 1
Staying Agile to Bring Therapies to Patients with Rare Diseases
Rare Diseases

Staying Agile to Bring Therapies to Patients with Rare Diseases

Sheila Frame

Amryt Pharma

PAO-06-022-CL-08Jun 21, 2022
Castle Creek Pharmaceuticals
Treatment

Castle Creek Pharmaceuticals Receives FDA Fast Track Designation for Diacerein 1% Ointment for Treatment of Epidermolysis Bullosa Simplex

Castle Creek Pharmaceuticals

PR-M08-18-NI-120Aug 31, 2018
RegeneRx
Joint Venture

RegeneRx Licensee GtreeBNT Enters into Joint Venture to Globally Develop RGN-137 for Treatment of Epidermolysis Bullosa

RegeneRx

PR-M08-18-NI-039Aug 10, 2018
1 / 1